Transformation of adrenal medullary chromaffin cells increases asthmatic susceptibility in pups from allergen-sensitized rats
© Feng et al.; licensee BioMed Central Ltd. 2012
Received: 31 July 2012
Accepted: 29 October 2012
Published: 8 November 2012
Studies have shown that epinephrine release is impaired in patients with asthma. The pregnancy of female rats (dams) with asthma promotes in their pups the differentiation of adrenal medulla chromaffin cells (AMCCs) into sympathetic neurons, mediated by nerve growth factor, which leads to a reduction in epinephrine secretion. However, the relatedness between the alteration of AMCCs and increased asthma susceptibility in such offspring has not been established.
In this study, we observed the effects of allergization via ovalbumin on rat pups born of asthmatic dams.
Compared to the offspring of untreated controls, bronchial hyperreactivity and airway inflammation were more severe in the pups from sensitized (asthmatic) dams. In pups exposed to nerve growth factor (NGF) in utero these effects were aggravated further, but the effects were blocked in pups whose dams had been treated with anti-NGF. Furthermore, alterations in AMCC phenotype corresponded to the degree of bronchial hyperreactivity and lung lesions of the different treatment groups. Such AMCC alterations included degranulation of chromaffin granules, reduction of epinephrine and phenylethanolamine-n-methyl transferase, and elevation of NGF and peripherin levels.
Our results present evidence that asthma during the pregnancy of rat dams promotes asthma susceptibility in their offspring, and that the transformation of AMCCs to neurons induced by NGF plays an important role in this process.
KeywordsMaternal asthma Offspring Susceptibility Adrenal medulla chromaffin cell Transformation
It is well known that maternal asthma is a risk factor for asthma in offspring [1, 2]. However, details of a causal mechanism remain unknown. Results from epigenetic studies have suggested that certain environmental exposures in utero are closely related to an asthmatic [3, 4]. Our recent data suggest that maternal asthma during pregnancy promotes adrenal medulla chromaffin cells (AMCCs) to differentiate into sympathetic neurons in rat pups. This in turn inhibits the maturity of the adrenal medulla, resulting in a decline in epinephrine (EPI) .
EPI is mainly secreted from AMCCs. AMCCs and sympathetic neurons originate from the same area in the neural crest, and it is well established that AMCCs retain the ability to transform from an endocrine to a neuronal phenotype in the presence of nerve growth factor (NGF) [6–8]. Sympathetic neurons synthesize and secrete norepinephrine and dopamine but not EPI. As a result, the secretion of EPI is impaired in transformed AMCCs, which leads to a decrease in EPI levels in the circulation.
Asthmatic attack is strongly related to dysfunctions in excitation and restraint of cholinergic nerves, adrenergic nerves, and their receptors. Human airway smooth muscles lack adrenergic nerves; the relaxation of airways is mainly regulated by EPI in circulation, which binds to the adrenergic receptors in airway smooth muscles. Studies have indicated that EPI levels were decreased in asthma patients [9, 10]. On the other hand, NGF levels were found increased in asthma patients. Moreover, NGF expression appeared to be correlated with the degree of bronchial hyper reactivity . Consistent with these results, our own previous studies indicated that the decline in EPI in asthma resulted from the transition of AMCCs to nerve cells, contributed to by elevated NGF [12, 13].
Currently, it is not known whether the alterations in AMCCs and asthma susceptibility of offspring from an asthmatic mother are related. In this study, the effects of ovalbumin (OVA) allergization on the offspring of female rats who themselves had OVA-induced asthma were investigated. We showed that maternal asthma during pregnancy promoted susceptibility to asthma in rat pups, and that the transformation of AMCCs to neurons induced by NGF exposure in utero played an important role in this process.
Experimental animals and preparation
All rats used in this study were from the Experimental Animal Center of Central South University (Changsha, China). This study was carried out in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health. The Ethics Committee of Asthma Research Institute, Hunan Province, China approved this study’s protocol.
Thirty-two pregnant Sprague–Dawley rats were randomly divided into four groups (n = 8 per group): control pregnant rats (CP), asthmatic pregnant rats (AP), NGF-treated pregnant rats (NP), and anti-NGF-treated pregnant rats (ANP). The rats were treated as in our previous study: on gestational days 0 and 7, all groups except the control rats were sensitized with an intraperitoneal (IP) injection of 100 mg of chicken OVA (Sigma, USA), 200 mg of aluminum hydroxide (Sigma, USA), and 6 × 109 heat-killed Bordetella pertussis (Wuhan Institute of Biological Products, China) in 1 mL of sterile saline. On the same days, the control rats were sham-sensitized without OVA. Subsequently, the OVA-sensitized rats were exposed to 30 min of 1% aerosol OVA (w/v) every day from days 14 to 21, while the control rats received filtered air only.
Thirty minutes prior to the inhalation treatments, rats in the NGF-treated group were IP-injected with NGF-7S (8 ng/kg, Sigma, USA, N0513) in phosphate buffered saline (PBS; 4 mL/kg). Those rats in the anti-NGF-treated group were IP-injected with anti-NGF (1:2000 dilution, Millipore, USA, 04–1119) in the same concentration of vehicle [13, 14]. The control and asthmatic rats received the vehicle only.
Measurement of bronchial responsiveness in offspring
In vivo airway responsiveness to histamine was measured 24 h after the last OVA challenge using a whole-body plethysmograph (PLY 3211, Buxco Electronics, USA). Rats were treated for 2 min with increasing doses of histamine generated by an ultrasonic nebulizer, after which airway resistance was measured. Airway resistance was measured at baseline and at the peak of reaction. Histamine-induced bronchoconstriction was reported for the peak of the reaction as the percent of change in resistance from the baseline value [15, 16].
Tissue preparation and hematoxylin and eosin (H&E) staining
All offspring rats were anesthetized using an IP injection of 10% chloral hydrate (350 mg/kg). The left adrenal glands were excised and either snap-frozen at −80°C and fixed in 4% paraformaldehyde, or fixed in 2% glutaraldehyde, according to subsequent usage. Serum was obtained from each rat. After the pulmonary artery was perfused, the right middle lung lobe was collected from each rat, fixed in 4% paraformaldehyde and then embedded in paraffin. Lung and adrenal medulla tissue sections (4 μm) were stained with H&E, and the morphological changes were observed under a light microscope.
Transmission electron microscopy in offspring
Adrenal medullae were fixed with 2% glutaraldehyde in 0.1 M cacodylate buffer, post-fixed in buffered 1% OsO4 for one hour, dehydrated in a graded ethanol series, and embedded in Epon-Araldite. Ultrathin sections (50 nm) were prepared from the different specimens and stained with uranyl acetate and lead citrate. Examinations of changes in ultrastructure were carried out with an H-7500 transmission electron microscope (TEM; Hitachi, Japan). Two pathologists who were blinded to the corresponding treatments assessed all samples.
Tissues fixed in 4% paraformaldehyde at 4°C overnight were embedded in paraffin, sectioned, and mounted on slides. The tissue sections were then deparaffinized in toluene and rehydrated in increased concentrations of ethanol. Quenching of endogenous peroxidase activity, incubation with antibodies and peroxidase staining were performed according to the instructions from the manufacturer (ABC kit, Zhongshan Biological,Beijing, China). Tissue sections were exposed to anti-phenylethanolamine-n-methyl transferase (PNMT) antibody (Millipore USA, AB110, 1:2500) at 4°C overnight. Detection was achieved using a 3-amino-9-ethyl-carbazole (AEC kit, Zhongshan Biological,Beijing, China) to convert the chromogenic AEC substrate to a colored precipitate, and the nuclei were stained with Gill’s hematoxylin and observed under a light microscope (100×).
Western blot analysis
Total proteins were extracted from tissue samples using RIPA lysis buffer (Takara, Japan). Thirty micrograms of protein were resolved via 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electrically transferred onto a polyvinylidene fluoride membrane at 120 V for 1.5 h. The transfer membrane was incubated with 0.05 g/mL skim milk at room temperature for 2 h. Rabbit anti-rat peripherin polyclonal antibody was then added (AB1530, 1:1000; Millipore) and incubated at 4°C overnight. After washing with PBS with Tween 20 (PBST), the membranes were incubated at 37°C for one hour with secondary antibodies (1:5000; Sigma) and visualized with an enhanced chemiluminescence system (Pierce Biotechnology, USA). β-actin was used as an internal control.
Real-time PCR analysis
Total RNA was extracted from the adrenal tissues using Trizol (Invitrogen, Carlsbad, CA, USA). Reverse transcription of RNA was performed using a kit for first-strand complementary DNA synthesis (Promega, Madison, MI, USA). A PCR kit with SYBR Green PCR Master Mix (Takara, Shiga, Japan) was used to analyze the mRNA expression of peripherin and GAPDH. Real-time PCR was performed using the ABI PRISM 7900-HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA). The primers were: peripherin, forward 5’-TGCTTCCCTAAGTTTAAAGACGAC-3' and reverse 5’-AGCTGTGAATAGAAGACTTGTCCA-3'; and GAPDH, forward 5’-TGACTTCAACAGCGACACCCA-3’ and reverse 5’-CACCCTGTTGCTGTAGCCAAA-3’. Real-time PCR data were analyzed according to the manufacturer’s instructions.
Enzyme linked immunosorbent assay (ELISA)
Levels of EPI, corticosterone, and NGF in serum were quantified using the ELISA Kit. Commercially-available antibodies were applied according to the manufacturer’s recommendations (EPI, 0100–0009, Serotec, USA; corticosterone, 500651–96, Cayman, USA; NGF, BT555, BPB Biomedical, USA). The reactions were measured at 450 nm with an ELISA reader (Wellscan MK3, Labsystems, Finland).
Data from offspring rats are presented as mean . One-way analysis of variance was used for multiple comparisons, followed by the Fisher’s protected (restricted) least significant difference test. A P-value less than 0.05 was considered statistically significant.
Airway responsiveness to histamine in offspring
Lung tissue morphology of offspring
Adrenal medulla alteration in offspring
Under the light microscope, vacuolar degeneration and lipids were observed in the adrenal medullae of OCP rats, and these pathological changes were aggravated in the OAP and ONP groups. Compared with the OAP group, the extent of lesions was much less in the OANP group (Figure 3E-H).
With the electron microscope, lesions such as degranulation of chromaffin granules and swollen cytoplasm and mitochondria were observed in the OCP rats, but these were more severe in the OAP and ONP groups. In addition, neurite-like processes were observed in chromaffin cells of the ONP rats. Compared with the OAP group, Lesions were absent in the OANP group, and the collagen tissues was deposited in AMCC in the OANP rats (Figure 3I-L).
Serum levels of EPI, corticosterone and NGF in offspring rats detected by ELISA
There was no significant difference found in serum corticosterone levels between the OCP and OAP groups (P > 0.05). However, compared with the OAP group the corticosterone level was significantly higher in the ONP rats, and significantly lower in the OANP rats (all P < 0.05; Figure 4B).
Similarly, serum NGF levels of OAP pups were significantly elevated compared to the OCP group, but those of the ONP (OANP) rats were significantly greater (less) than the OAP (all P < 0.05; Figure 4C).
The expression of PNMT in adrenal medulla of offspring rats detected by immunohistochemistry
The expression of peripherin in adrenal medulla of offspring rats detected by real-time PCR and Western blot
NGF, an important neurotrophic factor, was shown to increase in asthma and was related to the degree of bronchial hyperreactivity [11, 17]. Hyperinnervation of the airway was observed in transgenic mice overexpressing NGF, and these mice were more sensitive to capsaicin-induced increases in airway resistance . It has also been demonstrated that NGF increased sensory innervations, which led to changes in airway function . Some studies have indicated that anti-NGF decreased airway hyperresponsiveness caused by allergen challenge, and this could be a therapeutic strategy for the treatment of allergic asthma [13, 19–21]. We found recently that hyperinnervation of the adrenal medulla in asthmatic rats may contribute to the greater expression of NGF; the change of the adrenal medulla led to functional changes, which was associated with the transformation of AMCCs in asthma .
Because of a common origin from sympathoadrenal precursor cells, AMCCs can be transformed into sympathetic neurons under the stimulation of NGF, which is involved in neuronal growth, survival, and differentiation. An animal study indicated that prenatal injections of NGF, initiated in gestation and continued after birth with subcutaneous administration, produced massive transformation of chromaffin in sympathetic nerve cells of the adrenal medulla . We recently found that asthma during pregnancy induced a tendency toward transformation from AMCCs to sympathetic neurons in offspring rats, which was also related to elevated NGF in the asthmatic dams . These results suggested that the effect of NGF in asthma was strongly associated with the transformation of AMCCs.
In this study, all of pup groups (OCP, OAP, ONP, and OANP) were sensitized and challenged with OVA. In other words, all of pups were suffered from asthma, and the OCP pups were not the negative control pups but the asthmatic control pups. For this reason, the differences of NGF levels between OCP and OAP were existed (P < 0.05), but the changes may not be significant compared to that between the negative control and the asthmatic rats. It should be well noted that the differences in the function and ultrastructure of AMCCs were found among the four offspring groups from birth to adolescence prior to sensitization and challenge with OVA . Compared with the pups form control pregnant rats, the pups from asthmatic pregnant rats showed a trend toward transformation of AMCCs . When sensitized and challenged with OVA, the pathophysiology and phenotype changes of OAP rats were significant compared to that of OCP rats in this study. These results suggested that the susceptibility to OVA in asthmatic rats is also related to the phenotype state of AMCCs.
PNMT, the rate-limiting enzyme of EPI, is mainly expressed in adrenergic chromaffin cells but not in neurons. In this study, the expression of PNMT in OAP rats was lower than that of OCP rats, further reduction was found in ONP rats, and PNMT expression was enhanced in the OANP group. Interestingly, the level of PNMT in each group coincided with the expression of EPI. This indicated that the degree of injury in endocrine function of AMCCs was different among the four offspring groups, and related to the sensitivity to OVA.
Glucocorticoids are mainly secreted from the adrenal cortex. Similar to EPI, supplementing exogenous glucocorticoids is an effective treatment in asthma patients. Studies have shown that glucocorticoids could promote the expression of PNMT in the adrenal medulla, and that PNMT catalyzed the conversion of norepinephrine to EPI [23–25], which may be a mechanism underlying the value of glucocorticoids in the treatment of asthma. High concentration of glucocorticoids prevented fiber outgrowth from medullary chromaffin cells and inhibited the transformation of adrenal cells into neurons [26–28]. To a certain extent, the fate of AMCCs was determined by the balance of NGF and glucocorticoids in the milieu at any given time [28, 29].
In the present study, although the glucocorticoid levels were increased in the OAP and ONP groups compared to the OCP, yet there was also a tendency toward transformation of AMCCs to sympathetic neurons in these groups. These results may suggest that NGF predominately played a role in this process. In other words, the volume of glucocorticoids was insufficient to counter that of the NGF, and the effect of glucocorticoids in alleviating bronchospasm may be obviated by elevated NGF.
During the development and regeneration of nerve cells, peripherin (a type III intermediate filament) plays an important role in establishing cellular architecture by regulating axon formation . In fact, neurons with peripherin-siRNA demonstrated significantly impaired initiation, extension, and maintenance of neurites . AMCCs were implicated in the active downregulation of the intermediate filament protein that occurs during embryonic development . One study found that cells reactive to peripherin constituted a specific sub-population of AMCCs; this notion was supported by the fact that AMCCs, which highly expressed peripherin, had a distinct shape that was more like that of nerve cells .
In the present study, we showed that peripherin expression was higher in the OAP rats than in the OCP, and was higher still in the ONP, while reduced in the OANP. Accordingly, notable alterations in AMCCs such as neurite-like processes were found in the ONP rats. On the other hand, signs of reparation of AMCCs, such as collagen deposition, were found in the OANP rats. These results further indicate that the degree of alteration in AMCCs were significantly different among these offspring groups and suggests that peripherin plays a role in the transformation process.
Adrenal medulla chromaffin cell
Hematoxylin and eosin
Control pregnant rats
Asthmatic pregnant rats
NGF-treated pregnant rats
Anti-NGF-treated pregnant rats
Offspring from control pregnant rats
Offspring from asthmatic pregnant rats
Offspring from NGF-treated pregnant rats
Offspring from anti-NGF-treated pregnant rats
Nerve growth factor
This study was supported by grants from National Natural Science Foundation of China (Nos. 30800502, 30801505 and 81070026).
- Hamada K, Suzaki Y, Leme A, Ito T, Miyamoto K, Kobzik L, Kimura H: Exposure of pregnant mice to an air pollutant aerosol increases asthma susceptibility in offspring. J Toxicol Environ Health. 2007, 70 (8): 688-695. 10.1080/15287390600974692.View ArticleGoogle Scholar
- Ronchetti R, Jesenak M, Rennerova Z, Barreto M, Ronchetti F, Villa MP: Relationship between atopic asthma and the population prevalence rates for asthma or atopy in children: atopic and nonatopic asthma in epidemiology. Allergy Asthma Proc. 2009, 30 (1): 55-63. 10.2500/aap.2009.30.3197.PubMedView ArticleGoogle Scholar
- Hawrylowicz C, Ryanna K: Asthma and allergy: the early beginnings. Nat Med. 2010, 16 (3): 274-275. 10.1038/nm0310-274.PubMedView ArticleGoogle Scholar
- Martino D, Prescott S: Epigenetics and Prenatal Influences on Asthma and Allergic Airways Disease. Chest. 2011, 139 (3): 640-647. 10.1378/chest.10-1800.PubMedView ArticleGoogle Scholar
- Wu XM, Hu CP, Li XZ, Zou YQ, Zou JT, Li YY, Feng JT: Asthma Pregnancy Alters Postnatal Development of Chromaffin Cells in the Rat Adrenal Medulla. PLoS One. 2011, 6 (5): e20337-10.1371/journal.pone.0020337.PubMedPubMed CentralView ArticleGoogle Scholar
- Huber K, Kalcheim C, Unsicker K: The development of the chromaffin cell lineage from the neural crest. Auton Neurosci. 2009, 151 (1): 10-16. 10.1016/j.autneu.2009.07.020.PubMedView ArticleGoogle Scholar
- Morimoto M, Morita N, Kawata M: The effects of NGF and glucocorticoid on the cytological features of rat chromaffin cells in vitro. NeuroReport. 1994, 5 (8): 954-956. 10.1097/00001756-199404000-00025.PubMedView ArticleGoogle Scholar
- Unsicker K, Huber K, Schutz G, Kalcheim C: The chromaffin cell and its development. Neurochem Res. 2005, 30 (6–7): 921-925.PubMedView ArticleGoogle Scholar
- Barnes PJ, Brown MJ, Silverman M, Dollery CT: Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax. 1981, 36 (6): 435-440. 10.1136/thx.36.6.435.PubMedPubMed CentralView ArticleGoogle Scholar
- Ind PW, Causon RC, Brown MJ, Barnes PJ: Circulating catecholamines in acute asthma. Br Med J (Clin Res Ed). 1985, 290 (6464): 267-269. 10.1136/bmj.290.6464.267.View ArticleGoogle Scholar
- Bonini S, Lambiase A, Bonini S, Angelucci F, Magrini L, Manni L, Aloe L: Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA. 1996, 93 (20): 10955-10960. 10.1073/pnas.93.20.10955.PubMedPubMed CentralView ArticleGoogle Scholar
- Feng JT, Hu CP: Dysfunction of releasing adrenaline in asthma by nerve growth factor. Med Hypotheses. 2005, 65 (6): 1043-1046. 10.1016/j.mehy.2005.06.029.PubMedView ArticleGoogle Scholar
- Wang J, Hu CP, Feng JT: Dysfunction of releasing adrenaline in asthmatic adrenaline medullary chromaffin cells due to functional redundancy primed by nerve growth factor. Zhonghua Jie He He Hu Xi Za Zhi. 2006, 29 (12): 812-815.PubMedGoogle Scholar
- Hu C, Wedde-Beer K, Auais A, Rodriguez MM, Piedimonte G: Nerve growth factor and nerve growth factor receptors in respiratory syncytial virus-infected lungs. Am J Physiol Lung Cell Mol Physiol. 2002, 283 (2): L494-502.PubMedView ArticleGoogle Scholar
- Feng JT, Li XZ, Hu CP, Wang J, Nie HP: Neural plasticity occurs in the adrenal medulla of asthmatic rats. Chin Med J (Engl). 2010, 123 (10): 1333-1337.Google Scholar
- Jenkins CJ, Breslin AB: Long term study of the effect of sodium cromoglycate on non-specific bronchial hyperresponsiveness. Thorax. 1987, 42 (9): 664-669. 10.1136/thx.42.9.664.PubMedPubMed CentralView ArticleGoogle Scholar
- De Vries A, van Rijnsoever C, Engels F, Henricks PA, Nijkamp FP: The role of sensory nerve endings in nerve growth factor-induced airway hyperresponsiveness to histamine in guinea-pigs. Br J Pharmacol. 2001, 134 (4): 771-776. 10.1038/sj.bjp.0704310.PubMedView ArticleGoogle Scholar
- Hoyle GW, Graham RM, Finkelstein JB, Nguyen KP, Gozal D, Friedman M: Hyperinnervation of the airways in transgenic mice overexpressing nerve growth factor. Am J Respir Cell Mol Biol. 1998, 118 (2): 149-157.View ArticleGoogle Scholar
- De Vries A, Engels F, Henricks PA, Leusink-Muis T, Fischer A, Nijkamp FP: Antibodies directed against nerve growth factor inhibit the acute bronchoconstriction due to allergen challenge in guinea-pigs. Clin Exp Allergy. 2002, 32 (2): 325-328. 10.1046/j.1365-2222.2002.01283.x.PubMedView ArticleGoogle Scholar
- Glaab T, Hoymann HG, Hecht M, Korolewitz R, Tschernig T, Hohlfeld JM, Krug N, Braun A: Effect of anti-nerve growth factor on early and late airway responses in allergic rats. Allergy. 2003, 58 (9): 900-904. 10.1034/j.1398-9995.2003.00208.x.PubMedView ArticleGoogle Scholar
- Liu Y, Zhang B, Zhang S, Qi J, Zhang Z, Liu L, Fang X: Nerve growth factor mediated SH2-Bbeta/Akt signal pathway activated in allergic airway challenge in mice. Respirology. 2010, 15 (1): 80-7. 10.1111/j.1440-1843.2009.01648.x.PubMedView ArticleGoogle Scholar
- Aloe L, Levi-Montalcini R: Nerve growth factor-induced transformation of immature chromaffin cells in vivo into sympathetic neurons: effect of antiserum to nerve growth factor. Proc Natl Acad Sci USA. 1979, 76 (3): 1246-1250. 10.1073/pnas.76.3.1246.PubMedPubMed CentralView ArticleGoogle Scholar
- Evinger MJ, Towle AC, Park DH, Lee P, Joh TH: Glucocorticoids stimulate transcription of the rat phenylethanolamine N-methyltransferase (PNMT) gene in vivo and in vitro. Cell Mol Neurobiol. 1992, 12 (3): 193-215. 10.1007/BF00712926.PubMedView ArticleGoogle Scholar
- Kvetnansky R, Kubovcakova L, Tillinger A, Micutkova L, Krizanova O, Sabban EL: Gene expression of phenyl ethanolamine N-methyltransferase in corticotropin-releasing hormone knockout mice during stress exposure. Cell Mol Neurobiol. 2006, 26 (4–6): 735-754.PubMedGoogle Scholar
- Yamaguchi-Shima N, Okada S, Shimizu T, Usui D, Nakamura K, Lu L, Yokotani K: Adrenal adrenaline- and noradrenaline-containing cells and celiac sympathetic ganglia are differentially controlled by centrally administered corticotropin-releasing factor and arginine-vasopressin in rats. Eur J Pharmacol. 2007, 564 (1–3): 94-102.PubMedView ArticleGoogle Scholar
- Grumolato L, Louiset E, Alexandre D: PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors indifferentiating PC12 cells. Eur J Neurosci. 2003, 17 (1): 71-82. 10.1046/j.1460-9568.2003.02426.x.PubMedView ArticleGoogle Scholar
- Hodel A: Effects of glucocorticoids on adrenal chromaffin cells. J Neuroendocrinol. 2001, 13 (2): 216-220. 10.1046/j.1365-2826.2001.00628.x.PubMedView ArticleGoogle Scholar
- Unsicker K, Krisch B, Otten U, Thoenen H: Nerve growth factor-induced fiber outgrowth from isolated rat adrenal chromaffin cells: impairment by glucocorticoids. Proc Natl Acad Sci USA. 1978, 75 (7): 3498-3502. 10.1073/pnas.75.7.3498.PubMedPubMed CentralView ArticleGoogle Scholar
- Anderson DJ, Axel R: A bipotential neuroendocrine precursor whose choice of cell fate is determined by NGF and glucocorticoids. Cell. 1986, 47 (6): 1079-1090. 10.1016/0092-8674(86)90823-8.PubMedView ArticleGoogle Scholar
- Helfand BT, Mendez MG, Pugh J, Delsert C, Goldman RD: A role for intermediate filaments in determining and maintaining the shape of nerve cells. Mol Biol Cell. 2003, 14 (12): 5069-5081. 10.1091/mbc.E03-06-0376.PubMedPubMed CentralView ArticleGoogle Scholar
- Derer M, Grynszpan-Winograd O, Portier MM: Immunocytochemical localization of the intermediate filament protein peripherin in adult mouse adrenal chromaffin cells in culture. Neuroscience. 1989, 31 (2): 471-477. 10.1016/0306-4522(89)90389-8.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.